Clinical TrialsSearch results
Number of results: 58449
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase III Clinical Study on Taste Disorder by Z-103
-Double Blind Comparison Study on Patients with Zinc-Deficient and Idiopathic Taste Disorders -
- Zinc-Deficient and Idiopathic Taste Disorders
- ZERIA Pharmaceutical Co.,Ltd.
- 2006-04-10
Other
- Accelerative effect of polaprezinc on healing gastric ulcer after eradication of Helicobacter pylori infection
- Gastric ulcer with Helicobacter pylori infection
- Zeria Pharmaceutical Co.,LTD.
- 2005-09-13
Other
- Z-206 Phase III Clinical Trial
- Investigation on the remission-inducing effect in patients with Crohn's disease in active phase -
- Patients with Crohn's disease in active phase
- Zeria Pharmaceutical Co.,LTD
- 2005-12-22
Other
- ZO-SA0 PhaseIII clinical trial
- Cardiovascular disease
- Zeria Pharmaceutical Co., Ltd.
- 2014-01-06
Other
- Z-103 Phase III Clinical Study in patients with Taste Disorder - A placebo-controlled superiority study -
- taste disorders induced by zinc-deficiency
- Zeria Pharmaceutical Co., Ltd.
Other
- Therapeutic use of Z-521
- primary hypophosphatemic rickets
- Zeria Pharmaceutical Co., Ltd.
- 2010-11-02
Other
- Phase III Study of Z-206
- Ulcerative Colitis
- Zeria Pharmaceutical Co., Ltd.
Other
- Pharmacokinetic properties of the zinc agent polaprezinc in subjects with zinc deficiency
- male subjects
- Zeria Pharmaceutical Co., Ltd.
Other
- Exploratory Study of ZG-801 for the Treatment of Hyperkalemia
- Hyperkalemia
- Zeria Pharmaceutical Co., Ltd.
- 2019-02-04
Other
- A Phase III Trial of Z-338 in Paediatric Patients with Functional Dyspepsia
- Functional Dyspepsia
- Zeria Pharmaceutical Co., Ltd.
- 2020-08-25